Antibiotics

Five things for pharma marketers to know: Wednesday, September 21, 2016

Five things for pharma marketers to know: Wednesday, September 21, 2016

By

Drugmakers to remove incentives for sales reps marketing antibiotics; Mylan CEO defends EpiPen pricing; fitness trackers don't help people lose weight

Five things for pharma marketers to know: Monday, September 19, 2016

Five things for pharma marketers to know: Monday, September 19, 2016

By

Some U.S. hospitals still haven't received Valeant discounts; U.N. General Assembly will discuss antibiotic resistance; AstraZeneca diabetes drugs lowered blood sugar in study

Five things for pharma marketers to know: Friday, July 29, 2016

Five things for pharma marketers to know: Friday, July 29, 2016

By

England's NHS delays hep-C coverage due to pricing; Google reports 21% revenue growth; U.S. and U.K. announce partnership for antibiotic development

Five things for pharma marketers to know: Wednesday, June 15, 2016

Five things for pharma marketers to know: Wednesday, June 15, 2016

By

Hospitals struggle with high drug costs; the FDA approves new weight loss device; the ADA asks docs not to tweet, but they did anyway

Drugmakers renew interest in antibiotic development

Drugmakers renew interest in antibiotic development

By

The goal is to develop medications that move beyond the high-toxicity and low-efficacy profiles of older drugs.

TMC's McGuire preps CRE antibiotic for market

TMC's McGuire preps CRE antibiotic for market

By

The Medicines Company's commercial lead for infection disease care talks about its breakthrough antidote for carbapenem-resistant enterobacteriaceae.

OPINION

Email Newsletters